Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01169064 · ClinicalTrials.gov registry record · NA

Topical Silver for Prevention of Wound Infection After Cesarean Delivery

A NA study, sponsored by Vanderbilt University.

Terminated
Registry status
NA
Development phase
475
Enrollment target

NCT01169064 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 475 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01169064, a NA study, was terminated before completion, sponsored by Vanderbilt University.

TERMINATED
Registry status
NA
Development phase
475 participants
Enrollment target

Study Summary

A common concern in any surgical procedure is the occurrence of infection. Silver-containing treatments are popular and used in wound treatment; however, there is presently little evidence of the effectiveness of silver-containing treatment for the prevention of obstetrical wound infection. We plan to investigate the rate of infection in women experiencing cesarean sections at Vanderbilt University Medical Center (VUMC) by comparing the infection rate based on a randomized choice of silver-containing wound dressings to soft cloth adhesive wound dressings.

Interventions

  • DEVICE Silver-containing surgical dressing
  • DEVICE Cloth adhesive dressing

Trial Details

FieldValue
Enrollment Target 475 participants
Start Date 2010-07
Est. Completion 2012-07
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT01169064

The ClinicalTrials.gov registry entry for NCT01169064 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 475 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Silver-containing surgical dressing is the first listed.

NCT01169064 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01169064 about?

NCT01169064 is a clinical study titled "Topical Silver for Prevention of Wound Infection After Cesarean Delivery". A common concern in any surgical procedure is the occurrence of infection. Silver-containing treatments are popular and used in wound treatment; however, there is presently little evidence of the effectiveness of silver-containing treatment for the prevention of obstetrical wound infection. We plan ...

What is the current status of trial NCT01169064?

This trial is currently terminated. It is a NA study. The enrollment target is 475 participants. The study started on 2010-07. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01169064?

The interventions under investigation include: Silver-containing surgical dressing (DEVICE), Cloth adhesive dressing (DEVICE).

Who is sponsoring clinical trial NCT01169064?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.